Blog

Blog2018-05-01T17:49:07+00:00
18May 2020

COVID-19 Clinical Trials and Where to Get Treated: May 18, 2020 Update

May 18th, 2020|Categories: Clinical Trials, COVID-19|Tags: , , , , , |0 Comments

Here is a quick update on the ever-evolving world of COVID-19 trials.  Since our initial posting on this topic, three weeks ago, the number of trials has grown from 100 to over 300. The number of clinical facilities with clinical trials for COVID-19 has grown from 160 to over 600. [...]

20Apr 2020

COVID-19 Clinical Trials and Where to Get Treated

April 20th, 2020|Categories: Clinical Trials, COVID-19|Tags: , , , , , |0 Comments

We all know the basics for fighting the COVID-19 virus, like washing our hands and staying socially distant from one another, but what about future vaccines and treatments? There is a lot of talk right now about different companies making progress and potential treatments on their way, but what is [...]

30Jul 2019

When Good Things DON’T Come to Those Who Wait: How Pharma Companies Compare in Governance Efficiency

July 30th, 2019|Categories: Uncategorized|Tags: , , , |0 Comments

Predicting when a competing product will be approved is essential in any commercial forecast and for any business insights team with their eye on the market.  Here at OZMOSI, we have been spending our summer building out a machine learning approach to further improve our drug approval date forecasting.  Typically, [...]

1Jul 2019

Keeping up with the Pharmaceutical Industry in Asia

July 1st, 2019|Categories: Asia-Pacific Pharma Market, Business, Clinical Trials|Tags: , , , , , , , |0 Comments

Keeping up with pharmaceutical landscape around the world, especially in Asia, is essential in today’s market. Here are some of the biggest news stories emerging from Asian countries that are making big strides in drug development. China: Recently, China has been quickly advancing in the process of approving of [...]

10Oct 2018

China Reshaping the Clinical Trial Pipeline

October 10th, 2018|Categories: Asia-Pacific Pharma Market, Clinical Trials|Tags: , |0 Comments

Finally, the data is in here at OZMOSI, and we can start tracking and reporting on the clinical development expected to come out of China.  Gone are the days of developing drugs only in the US and then watching them slowly make their way to the rest of the world. [...]

27Sep 2018

The Clinical Trial Powershift

September 27th, 2018|Categories: Clinical Trials|Tags: , , , , |0 Comments

Pharmaceutical companies are being pushed aside when it comes to who is driving clinical outcomes. Despite the growing number of industry trials year over year, the pharmaceutical industry is taking a back seat to the even faster growing hospital groups and universities in the same space.  Looking back to the [...]